Before surgery, a biopsy gene test could reveal which lung tumors are likely to recur

Lung cancer is the leading cause of death from cancer. It kills more people in the U.S. than breast, prostate, and colon ...
Morningstar

Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After ...

Data published in Journal of Clinical Oncology supports routine use of circulating tumor DNA (ctDNA) testing in management of stage III colon cancer patients Guardant Health, Inc. (Nasdaq: GH), a ...
Seeking Alpha

Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After ...

Data published in Journal of Clinical Oncology supports routine use of circulating tumor DNA (ctDNA) testing in management of stage III colon cancer patients Researchers found that about 20 percent of ...